REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 186 filers reported holding REGENXBIO INC in Q4 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,170,300 | -30.8% | 131,853 | -16.0% | 0.01% | -27.8% |
Q2 2023 | $3,138,190 | +28.6% | 156,988 | +21.7% | 0.02% | +5.9% |
Q1 2023 | $2,439,674 | -24.9% | 129,015 | -9.9% | 0.02% | -37.0% |
Q4 2022 | $3,248,842 | +5.0% | 143,247 | +22.3% | 0.03% | -18.2% |
Q3 2022 | $3,095,000 | +60.3% | 117,107 | +49.8% | 0.03% | +83.3% |
Q2 2022 | $1,931,000 | -50.1% | 78,193 | -33.0% | 0.02% | -21.7% |
Q1 2022 | $3,871,000 | +2.0% | 116,640 | +0.5% | 0.02% | +15.0% |
Q4 2021 | $3,795,000 | +27.9% | 116,064 | +64.0% | 0.02% | 0.0% |
Q3 2021 | $2,967,000 | +19.2% | 70,779 | +10.4% | 0.02% | +25.0% |
Q2 2021 | $2,490,000 | -10.7% | 64,090 | -21.6% | 0.02% | -15.8% |
Q1 2021 | $2,787,000 | +399.5% | 81,709 | +563.8% | 0.02% | +280.0% |
Q4 2020 | $558,000 | -55.7% | 12,309 | -73.1% | 0.01% | -66.7% |
Q3 2020 | $1,259,000 | +60.8% | 45,766 | +115.2% | 0.02% | +36.4% |
Q2 2020 | $783,000 | -61.6% | 21,270 | -57.3% | 0.01% | -64.5% |
Q4 2019 | $2,040,000 | -50.9% | 49,799 | -57.3% | 0.03% | -52.3% |
Q3 2019 | $4,153,000 | -15.5% | 116,655 | +22.0% | 0.06% | -24.4% |
Q2 2019 | $4,913,000 | +48.1% | 95,640 | +65.2% | 0.09% | +62.3% |
Q1 2019 | $3,318,000 | – | 57,898 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 1,459,128 | $110,164,000 | 6.60% |
ArchPoint Investors | 224,187 | $16,926,000 | 4.60% |
Redmile Group, LLC | 1,656,065 | $125,033,000 | 3.85% |
WS MANAGEMENT LLLP | 954,812 | $72,088,000 | 2.37% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 342,000 | $25,821,000 | 1.19% |
Perceptive Advisors | 470,672 | $35,536,000 | 0.95% |
Pier Capital, LLC | 94,492 | $7,134,000 | 0.90% |
Ipswich Investment Management Co., Inc. | 29,932 | $2,260,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 275,000 | $20,763,000 | 0.74% |
Timpani Capital Management LLC | 27,835 | $2,102,000 | 0.61% |